{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:54:42Z","timestamp":1790488482862,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3446,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1038\/sj.ki.5000417","type":"journal-article","created":{"date-parts":[[2006,5,24]],"date-time":"2006-05-24T14:21:17Z","timestamp":1148480477000},"page":"26-33","source":"Crossref","is-referenced-by-count":190,"title":["Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective"],"prefix":"10.1016","volume":"70","author":[{"given":"C.","family":"Zoccali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5000417_bb0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0002-9149(76)90061-8","article-title":"A general cardiovascular risk profile: the Framinham Study","volume":"38","author":"Kannel","year":"1976","journal-title":"Am J Cardiol"},{"key":"10.1038\/sj.ki.5000417_bb0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1681\/ASN.2004070539","article-title":"Chronic kidney disease awareness, prevalence, and trends among US adults, 1999\u20132000","volume":"16","author":"Coresh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/0003-4819-141-2-200407200-00007","article-title":"The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency","volume":"141","author":"Hsu","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1038\/sj.ki.5000417_bb0025","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/archinte.159.15.1785","article-title":"Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study","volume":"159","author":"Culleton","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1038\/sj.ki.5000417_bb0030","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of new-onset kidney disease in a community based population","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1038\/sj.ki.5000417_bb0035","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/01.ASN.0000070152.11927.4A","article-title":"Prevalence of kidney damage in Australian adults: The AusDiab kidney study","volume":"14","author":"Chadban","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-133-8-200010170-00008","article-title":"Smoking is related to albuminuria and abnormal renal function in nondiabetic persons","volume":"133","author":"Pinto-Sietsma","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1038\/sj.ki.5000417_bb0045","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/j.1523-1755.2004.09205.x","article-title":"PREVEND Study Group. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population","volume":"92","author":"Verhave","year":"2004","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/sj.ki.5000417_bb0050","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1681\/ASN.2005010106","article-title":"Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults","volume":"16","author":"Kurella","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1038\/sj.ki.5000417_bb0055","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/01.ASN.0000070144.86024.04","article-title":"Screening for chronic kidney disease: unresolved issues","volume":"14","author":"McClellan","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0060","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1001\/jama.1993.03500100070030","article-title":"Projections of hypertension-related renal disease in middle-aged residents of the United Status","volume":"269","author":"Perneger","year":"1993","journal-title":"JAMA"},{"key":"10.1038\/sj.ki.5000417_bb0065","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/01.ASN.0000127045.14709.75","article-title":"Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients","volume":"15","author":"Segura","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0070","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1097\/01.ASN.0000129982.10611.4C","article-title":"Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease","volume":"15","author":"McClellan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0075","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.CIR.0000116764.53225.A9","article-title":"Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study","volume":"109","author":"McAlister","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000417_bb0080","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/01.ASN.0000135121.81744.75","article-title":"Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial","volume":"15","author":"Shlipak","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0085","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","article-title":"Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency","volume":"56","author":"Culleton","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","article-title":"Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community","volume":"41","author":"Manjunath","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/sj.ki.5000417_bb0095","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1046\/j.1523-1755.2002.00270.x","article-title":"Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I","volume":"61","author":"Garg","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.V133745","article-title":"Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States","volume":"13","author":"Muntner","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0105","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/01.ASN.0000123691.46138.E2","article-title":"Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies","volume":"15","author":"Weiner","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0110","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.161.6.886","article-title":"High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension","volume":"161","author":"Schillaci","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1038\/sj.ki.5000417_bb0115","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/01.ASN.0000027871.86296.92","article-title":"Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial","volume":"13","author":"De Leeuw","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0120","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000417_bb0125","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"23","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000417_bb0130","first-page":"S16","article-title":"Epidemiology of cardiovascular disease in chronic renal disease","volume":"9","author":"Foley","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0135","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1001\/archinte.161.22.2657","article-title":"The real contribution of the major risk factors to the coronary epidemics: time to end the \u2018only-50%\u2019 myth","volume":"161","author":"Magnus","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1038\/sj.ki.5000417_bb0140","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case\u2013control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5000417_bb0145","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5414\/CNP57327","article-title":"Cardiovascular disease risk factors in chronic renal insufficiency","volume":"57","author":"Sarnak","year":"2002","journal-title":"Clin Nephrol"},{"issue":"Suppl 85","key":"10.1038\/sj.ki.5000417_bb0150","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1046\/j.1523-1755.63.s85.25.x","article-title":"Traditional and emerging cardiovascular risk factors in end-stage renal disease","volume":"63","author":"Zoccali","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0155","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ndt\/gfg074","article-title":"Oxidative stress in end-stage renal disease: an emerging threat to patient outcome","volume":"18","author":"Locatelli","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000417_bb0160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V131134","article-title":"Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0165","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMra011078","article-title":"Mechanisms of disease: subtle acquired renal injury as a mechanism of salt-sensitive hypertension","volume":"346","author":"Johnson","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1038\/sj.ki.5000417_bb0170","first-page":"S29","article-title":"Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis","volume":"31","author":"Diamond","year":"1991","journal-title":"Kidney Int"},{"issue":"Suppl","key":"10.1038\/sj.ki.5000417_bb0175","first-page":"S40","article-title":"Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria","volume":"63","author":"Brocco","year":"1997","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","article-title":"Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin","volume":"34","author":"Levin","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000417_bb0185","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1523-1755.2004.00797.x","article-title":"Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial","volume":"66","author":"Gouva","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpcardio0094","article-title":"Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome","volume":"2","author":"Iaina","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1038\/sj.ki.5000417_bb0195","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.ajkd.2005.09.007","article-title":"Evidence-based systematic literature review of hemoglobin\/hematocrit and all-cause mortality in dialysis patients","volume":"47","author":"Volkova","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000417_bb0200","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1097\/01.ASN.0000034202.91413.EB","article-title":"The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease","volume":"13","author":"De Boer","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1523-1755.2005.00421.x","article-title":"Pathogenesis of vascular calcification in chronic kidney disease","volume":"68","author":"Cozzolino","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0215","first-page":"221","article-title":"The clinical management of hyperphosphatemia","volume":"218","author":"Ritz","year":"2005","journal-title":"J Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.ki.4495353","article-title":"Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study","volume":"54","author":"Hoogeveen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0225","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0272-6386(04)00813-3","article-title":"Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study","volume":"44","author":"Ninomiya","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"Suppl","key":"10.1038\/sj.ki.5000417_bb0230","first-page":"S72","article-title":"Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients","volume":"41","author":"Chauveau","year":"1997","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0235","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"issue":"Suppl 3","key":"10.1038\/sj.ki.5000417_bb0240","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1177\/089686080502503S21","article-title":"Clinical epidemiology of non-traditional risk factors in peritoneal dialysis patients","volume":"25","author":"Zoccali","year":"2005","journal-title":"Peritoneal Dial Int"},{"key":"10.1038\/sj.ki.5000417_bb0245","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1523-1755.2002.00144.x","article-title":"Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients","volume":"61","author":"Mallamaci","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1081\/JDI-120002659","article-title":"The association of interdialytic weight gain with nutritional parameters and mortality risk in hemodialysis patients","volume":"24","author":"Sezer","year":"2002","journal-title":"Ren Fail"},{"key":"10.1038\/sj.ki.5000417_bb0255","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1523-1755.2003.00762.x","article-title":"C-reactive protein is associated with renal function abnormalities in a non-diabetic population","volume":"63","author":"Stuveling","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0260","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000417_bb0265","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.104.517565","article-title":"Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000417_bb0270","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.0000143892.84582.60","article-title":"Effect of pravastatin on cardiovascular events in people with chronic kidney disease","volume":"110","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000417_bb0275","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.ajkd.2003.10.037","article-title":"Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study","volume":"43","author":"Landray","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000417_bb0280","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0285","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00004872-200018090-00006","article-title":"Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed investigators. Cardiovascular risk extended evaluation in dialysis patients","volume":"18","author":"Zoccali","year":"2000","journal-title":"J Hypertens"},{"key":"10.1038\/sj.ki.5000417_bb0290","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2002.00637.x","article-title":"Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage?","volume":"62","author":"Stenvinkel","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0295","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0272-6386(00)70200-9","article-title":"C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000417_bb0300","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000417_bb0305","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/hc0502.102969","article-title":"Monocyte\/macrophage regulation of vascular calcification in vitro","volume":"105","author":"Tintut","year":"2002","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000417_bb0310","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.ASN.0000038685.95946.83","article-title":"Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study","volume":"14","author":"Wang","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 84","key":"10.1038\/sj.ki.5000417_bb0315","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1046\/j.1523-1755.63.s84.20.x","article-title":"Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease","volume":"63","author":"Kaysen","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000417_bb0320","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2362.2003.01169.x","article-title":"Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure","volume":"33","author":"Zoccali","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1038\/sj.ki.5000417_bb0325","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2796.2003.01180.x","article-title":"Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure","volume":"254","author":"Zoccali","year":"2003","journal-title":"J Intern Med"},{"key":"10.1038\/sj.ki.5000417_bb0330","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJM199904293401704","article-title":"Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure","volume":"340","author":"Ligtenberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000417_bb0335","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/hc1102.105261","article-title":"Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease","volume":"105","author":"Zoccali","year":"2002","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000417_bb0340","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-201X.2003.01091.x","article-title":"Sympathetic nerve activity in obstructive sleep apnoea","volume":"177","author":"Narkiewicz","year":"2003","journal-title":"Acta Physiol Scand"},{"key":"10.1038\/sj.ki.5000417_bb0345","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1681\/ASN.V133729","article-title":"Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.HYP.0000022063.50739.60","article-title":"Norepinephrine and concentric hypertrophy in patients with end-stage renal disease","volume":"40","author":"Zoccali","year":"2002","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5000417_bb0355","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.CIR.0000138745.21879.27","article-title":"Endothelial dysfunction and mild renal insufficiency in essential hypertension","volume":"17","author":"Perticone","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000417_bb0360","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.V131170","article-title":"Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease","volume":"13","author":"Kielstein","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0365","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/01.CIR.0000105764.22626.B1","article-title":"Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans","volume":"109","author":"Kielstein","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000417_bb0370","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.CIR.101.8.856","article-title":"Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake","volume":"101","author":"Fujiwara","year":"2000","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1038\/sj.ki.5000417_bb0375","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/ndt\/16.suppl_1.60","article-title":"The role of nitric oxide in hypertension and renal disease progression","volume":"16","author":"Klahr","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000417_bb0380","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach","volume":"16","author":"Ravani","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0385","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study","volume":"16","author":"Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0390","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5000417_bb0395","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5000417_bb0400","first-page":"G154","article-title":"Nitric oxide-mediated excitatory effect on neurons of dorsal motor nucleus of vagus","volume":"266","author":"Travagli","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1038\/sj.ki.5000417_bb0405","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0735-1097(01)01786-7","article-title":"Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation","volume":"39","author":"Hijmering","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/sj.ki.5000417_bb0410","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.ASN.0000106717.58091.F6","article-title":"Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease","volume":"15","author":"Mallamaci","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000417_bb0415","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in US adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1038\/sj.ki.5000417_bb0420","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.ki.5000085","article-title":"Global approach to cardiovascular risk in chronic kidney disease","volume":"69","author":"De Nicola","year":"2006","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1038\/sj.ki.5000417_bb0425","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/16.suppl_2.16","article-title":"Cardiovascular risk Reduction by Early Anemia Treatment with Epoetin Beta (CREATE) Trial. The CREATE trial \u2013 building the evidence","volume":"16","author":"Eckardt","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000417_bb0430","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.ajkd.2004.11.015","article-title":"First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease","volume":"45","author":"Baigent","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000417_bb0435","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJMsa035507","article-title":"Shattuck lecture. Clinical research to clinical practice: lost in translation?","volume":"49","author":"Lenfant","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815517432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815517432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T16:02:25Z","timestamp":1627401745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815517432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0085253815517432"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5000417","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}